{"id":51548,"date":"2020-03-21T01:00:00","date_gmt":"2020-03-21T05:00:00","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=51548"},"modified":"2023-06-23T11:14:46","modified_gmt":"2023-06-23T16:14:46","slug":"ndasa-2020-conference-overview","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/ndasa-2020-conference-overview\/","title":{"rendered":"NDASA 2020 Conference Overview Video"},"content":{"rendered":"\n

Over the years at many industry conferences, we have seen write-ups of the important and fun highlights from those events.  We decided to record and show a video of, what we believe to be the highlights and especially our team\u2019s involvement<\/strong> in the latest drug testing industry conference<\/strong>. This will probably be the last conference of 2020 for the drug and alcohol testing industry.<\/p>\n\n\n\n

NDASA<\/a> \u2013 the National Drug & Alcohol Screening Association, was fortunate to be able to hold their annual conference just before the serious travel restrictions and social distancing guidelines recently put out by the Federal Government.  There was a large lively crowd celebrating this year\u2019s success in the drug testing industry.  The NDASA 2020 Annual Conference & Trade Show was held in beautiful Jacksonville, FL on March 9-11, 2020.<\/p>\n\n\n\n

We hope you enjoy our conference overview video.  We also have additional video recordings which we will post over the next few months.  Our videos are always available on the National Drug Screening YouTube Channel<\/a>. Also look to NDASA<\/a> for video recordings about the organization and all the great things going on, they are working hard for our industry.<\/p>\n\n\n\n

NDASA Chairman Jim Greer and Executive Director Jo McGuire provided a great agenda for spectacular keynote speakers, relevant break-out workshops, excellent training classes and meaningful networking opportunities.  A lively trade show ended with a live auction and several lucky bidders obtaining weeklong vacations at a beautiful condo in Cocoa Beach, FL.<\/p>\n\n\n\n

Miss America 2020, Camille Schrier was a featured speaker along with keynote speaker Mike Lindell former crack addict and now CEO of My Pillow.  Both provided excellent messages to the drug testing industry based their own life experiences.<\/p>\n\n\n\n

Other great workshops included information on DOT drug testing regulations, fake urine, cheating on drug tests, FMCSA Clearinghouse and new SAMHSA guidelines for oral fluid testing.  NDASA held its governmental affairs committee meeting, its political action committee (PAC) meeting and the annual membership meeting of National Drug & Alcohol Screening Association (NDASA).  The leading drug testing industry association is strong, active, vibrant and healthy.<\/p>\n\n\n\n

National Drug Screening <\/a>was proud to be part of this 2nd<\/sup> annual conference for NDASA.  As an exhibitor with 4 of our team members attending; we learned, we networked, and we learned more.  Also, always great to catch up with customers, prospects, new and old friends.<\/p>\n\n\n\n

It was our honor to have Ryan Scott of 3 Arrows Creative shoot some great video for us to share with NDASA and the industry.\u00a0 Thank you, Ryan, for joining and for providing the video shoot and production.<\/p>\n\n\n\n

Be on the lookout for next year\u2019s NDASA conference \u2013 NDASA says \u201cMeet Us in St. Louis May 25-27, 2021\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

Over the years at many industry conferences, we have seen write-ups of the important and fun highlights from those events.  We decided to record and show a video of, what we believe to be the highlights and especially our team\u2019s involvement in the latest drug testing industry conference. This will probably be the last conference […]<\/p>\n","protected":false},"author":12,"featured_media":54139,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51534,51068,51392,51255,51362,50856","_relevanssi_noindex_reason":"","footnotes":""},"categories":[77],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51548"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51548"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51548\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/54139"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}